Endoscopic Radiofrequency Ablation of Celiac Ganglion for Pain Management and Improvement of Quality of Life in Patients With Unresectable Pancreatic Cancer

Who May Qualify: - Diagnosis of pancreatic cancer based on clinical, radiological, or pathological assessment; - Referred for abdominal and/or back pain due to pancreatic cancer; - No prior history of RFA; - Cancer pain unresponsive to the WHO 3-step analgesic ladder; - Willingness to consent to participate in the study. Who Should NOT Join This Trial: - Patients who are not willing to give willing to sign a consent form or agree to participate in the study - Surgically resectable pancreatic cancer; - Abdominal pain with etiology other than pancreatic malignancy; - Evidence of concurrent infection; - Patients with irreversible coagulopathy international normalized ratio \>1.5 or platelet count \<50,000/mm3), - Patients with a preliminary diagnosis of adenocarcinoma are not possible established with intraprocedural at EUS-guided FNA. Always talk to your doctor about whether this trial is right for you.